Company intelligence / Profile preview

Laboratoire L. Lafon

Maisons-Alfort, France

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Laboratoire L. Lafon was a French pharmaceutical company founded by Louis Lafon, primarily recognized for its pioneering work in the discovery and development of modafinil. The company specialized in central nervous system (CNS) therapeutics, particularly wakefulness-promoting agents used to treat narcolepsy and other sleep disorders. In 2001, the company was acquired by Cephalon for approximately 450 million USD, which was subsequently acquired by Teva Pharmaceutical Industries in 2011. Today, the legacy of Laboratoire L. Lafon continues through the global commercialization of its CNS portfolio under the Teva brand.

Therapeutic areas: PulmonologyNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

Cephalon

Beyond the preview

Go deeper on Laboratoire L. Lafon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratoire L. Lafon.

Explore the full profile